Latest news with #EdClarke
Business Wire
31-07-2025
- Health
- Business Wire
Aetna Marks 3 Years of Type 2 Diabetes Reversal through Virta Health, Thousands See Results
PHOENIX--(BUSINESS WIRE)-- Banner|Aetna, a joint venture health plan owned by Banner Health and Aetna, a CVS Health company, celebrates three years of investing in members by offering an evidence-based diabetes reversal initiative. In 2022, the insurer was an early adopter of Virta Health for diabetes reversal – the process of reducing blood glucose levels to below the threshold used to diagnose diabetes. 1 Since then, the program enrollment has grown 290% and thousands of members have achieved sustainable health transformations while reducing their need for expensive weight loss medications, like Wegovy and Ozempic. 2 The flexible app-based program uses a virtual model to address the root cause of metabolic disease through individualized nutrition plans that fit members' unique lifestyles, cultural background, dietary preferences, and budget. Thanks to the personalized approach and one-on-one expert support, participants are experiencing significant and lasting outcomes. Recent data shows that Banner|Aetna members saw meaningful metabolic health improvements after 365 days of program enrollment, including the following. Blood sugar reduction: On average, members saw a 0.97% reduction in A1C blood sugar levels. 3 Every one-point decrease in A1C reduces the risk of long-term diabetes complications by up to 40%. Prescription reduction: Members eliminated 57% of diabetes medications (excluding metformin), including a 66% reduction in insulin dosages. Of those on insulin, 44% eliminated it completely. 4 Clinically significant weight loss: 61% of members experienced clinically significant weight loss (5% or more); on average, members lost 8% of their body weight. 5 Clinically significant weight loss can lead to better sleep, reduced inflammation, improved blood pressure, reduced risk of heart disease and positive impacts on arthritis and fatty liver disease. In addition to the diabetes reversal program demonstrating outstanding clinical results, Banner|Aetna's omnichannel outreach approach achieves 3x higher member engagement compared to industry averages. 6 Through deep integration with Banner Health—one of Banner|Aetna's parent companies and Arizona's largest healthcare delivery system—the insurer leverages the Banner Health clinical and care management teams to refer eligible members into a diabetes management program. 'The U.S. is facing a metabolic disease crisis. One in 10 people lives with diabetes, and most have type 2. One in three has prediabetes,' explains Ed Clarke, MD, Banner|Aetna Medical Director and VP, CMO Banner Plans & Networks. 'These conditions take a toll on the physical, emotional and financial health of millions of people in Arizona. That's why Banner|Aetna collaborated with Virta to offer members a holistic, non-pharmacological approach that puts disease reversal within reach. The feedback from members who have completed the program shows its dramatic impact on their lives. Not only do they gain a better understanding of disease management, but more importantly how they can take control health of their health.' The results speak for themselves as members are achieving notable clinical outcomes helping them reclaim their lives, while also having a positive effect that ripples out to their families and the broader community. For Banner|Aetna member Shelby*, learning to use food as medicine has led to 'amazing' changes in her life, including increased energy, better sleep, and weight loss. 'I have learned how my body reacts to a wide array of foods and what I can eat to help it flourish,' she explains. 'I am very thankful for the support my coach provides every step of the way, and her encouragement that I am worth the hard work.' Banner|Aetna currently offers type 2 diabetes reversal to eligible members of fully insured and Administrative Services Only groups. Additionally, Banner|Aetna self-funded employer groups can access Virta's prediabetes and obesity reversal offerings, which use the same innovative care model. About Banner|Aetna Banner|Aetna is a health insurance company focusing on bettering member outcomes at a lower cost, all while improving the overall member experience for employers and consumers in Arizona. The collaboration combines Banner Health's quality, local providers and delivery systems with Aetna's health-plan experience, care management and health information technology. Banner|Aetna is the brand name used for products and services provided by Banner Health and Aetna Health Insurance Company and Banner Health and Aetna Health Plan Inc. For more information about Banner|Aetna, visit About Banner Health Banner Health is one of the largest, secular nonprofit health care systems in the country. In addition to 33 hospitals, Banner also operates an academic medicine division, Banner – University Medicine, and Banner MD Anderson Cancer Center, a partnership with one of the world's leading cancer programs, MD Anderson Cancer Center. Banner's array of services includes a health insurance division, employed physician groups, outpatient surgery centers, urgent care locations, home care and hospice services, retail pharmacies, stand-alone imaging centers, physical therapy and rehabilitation, behavioral health services, a research division and a nursing registry. To make health care easier, 100% of Banner-employed doctors are available for virtual visits and patients may also reserve spots at Banner Urgent Care locations and can book appointments online with many Banner-employed doctors. Headquartered in Arizona, Banner Health also has locations in California, Colorado, Nebraska, Nevada and Wyoming. For more information, visit About CVS Health CVS Health is a leading health solutions company building a world of health around every consumer, wherever they are. As of March 31, 2025, the Company had more than 9,000 retail pharmacy locations, more than 1,000 walk-in and primary care medical clinics, a leading pharmacy benefits manager with approximately 88 million plan members, and a dedicated senior pharmacy care business serving more than 800,000 patients per year. The Company also serves an estimated more than 37 million people through traditional, voluntary and consumer-directed health insurance products and related services, including highly rated Medicare Advantage offerings and a leading standalone Medicare Part D prescription drug plan. The Company's integrated model uses personalized, technology driven services to connect people to simply better health, increasing access to quality care, delivering better outcomes, and lowering overall costs. 1 Riddle MC, Cefalu WT, Evans PH et al. Consensus Report: Definition and Interpretation of Remission in Type 2 Diabetes. Diabetes Care 1 October 2021; 44 (10): 2438–2444. 2 Virta Health & Banner|Aetna Clinical Outcomes. March 31, 2025. 3 Virta Health & Banner|Aetna Clinical Outcomes. February 27, 2025. 4 Ibid. 5 Ibid. 6 Engagement data reported by Virta Health. January 2023-May 2025. * The member's uncompensated testimonial reflects the enrollee's experience with Virta Health.
Cision Canada
24-06-2025
- Business
- Cision Canada
Major Disability Care Provider Initiates On-Premise Deployment
[email protected] Highlights: Evaluation deployment originated by a major provider from inbound demand and marks the first deployment of Inturai technology in disability care sector Disability care is a natural extension of aged care use cases and a CAD $91.2b market by 2030* Based in New Zealand, the outcome of the program will define rollout discussions across the provider's national footprint Click to Visit The Inturai YouTube Channel VANCOUVER, BC, June 24, 2025 /CNW/ - P2P Group Ltd. (CSE: PPB) (FSE: 3QG) (US: PPBGF) is pleased to announce that a major New Zealand-based disability care provider is commencing an on-premise trial of the Inturai platform. The trial represents the first in-market deployment of Inturai's real-time sensing and activity recognition system in the disability care sector. It will focus on delivering enhanced safety, privacy and quality of life outcomes through Inturai's AI-driven, hardware-free monitoring solution. This initial phase includes live testing in test and residential environments, aiming to validate use cases such as event detection, activity mapping and responsive care alerting, without the use of invasive cameras or wearable devices to maintain client dignity. "This is a high-trust sector where dignity and safety must be delivered together," said Ed Clarke, CEO of P2P Group. "We are proud to see our platform entering the trial stage with one of New Zealand's leading care providers. It's a significant milestone in expanding our health sector impact." Trial results will be used to inform planning for broader rollout across the provider's national operations, pending successful outcomes and stakeholder engagement. Updates will be provided should they become material. About P2P Group P2P Group is advancing intelligent environments through its proprietary Inturai AI signal sensing technology, transforming sectors including healthcare, defence, policing, emergency services, drones, smart homes, and industrial systems. By leveraging standard Wi-Fi and radio signals, Inturai delivers next-generation spatial intelligence without the need for invasive or specialist hardware. This breakthrough enables safer, smarter spaces across a range of high-impact use cases. To learn more, visit This document contains certain forward-looking statements that are based on assumptions as of the date of this news release. Forward-looking statements are frequently characterised by words such as "anticipates", "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed", "positioned" and other similar words, or statements that certain events or conditions "may" or "will" occur. All such forward-looking statements involve substantial known and unknown risks and uncertainties, certain of which are beyond the Company's control. The reader is cautioned that the assumptions used in the preparation of the forward-looking statements may prove to be incorrect and the actual results, performance or achievements could differ materially from those expressed in, or implied by, these forward-looking statements. Accordingly, no assurances can be given that any of the events anticipated by the forward-looking statements will transpire or occur, or if any of them do, what benefits, including the amount of proceeds, the Company will derive therefrom. Readers are cautioned that the foregoing list of factors is not exhaustive. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.
Yahoo
24-06-2025
- Business
- Yahoo
Major Disability Care Provider Initiates On-Premise Deployment
(CSE: PPB / FSE: 3QG / US: PPBGF)investor@ Highlights: Evaluation deployment originated by a major provider from inbound demand and marks the first deployment of Inturai technology in disability care sector Disability care is a natural extension of aged care use cases and a CAD $91.2b market by 2030* Based in New Zealand, the outcome of the program will define rollout discussions across the provider's national footprint Click to Join Our Telegram Channelhttps:// Click to Visit The Inturai YouTube Channelhttps:// VANCOUVER, BC, June 24, 2025 /CNW/ - P2P Group Ltd. (CSE: PPB) (FSE: 3QG) (US: PPBGF) is pleased to announce that a major New Zealand-based disability care provider is commencing an on-premise trial of the Inturai platform. The trial represents the first in-market deployment of Inturai's real-time sensing and activity recognition system in the disability care sector. It will focus on delivering enhanced safety, privacy and quality of life outcomes through Inturai's AI-driven, hardware-free monitoring solution. This initial phase includes live testing in test and residential environments, aiming to validate use cases such as event detection, activity mapping and responsive care alerting, without the use of invasive cameras or wearable devices to maintain client dignity. "This is a high-trust sector where dignity and safety must be delivered together," said Ed Clarke, CEO of P2P Group. "We are proud to see our platform entering the trial stage with one of New Zealand's leading care providers. It's a significant milestone in expanding our health sector impact." Trial results will be used to inform planning for broader rollout across the provider's national operations, pending successful outcomes and stakeholder engagement. Updates will be provided should they become material. * About P2P Group P2P Group is advancing intelligent environments through its proprietary Inturai AI signal sensing technology, transforming sectors including healthcare, defence, policing, emergency services, drones, smart homes, and industrial systems. By leveraging standard Wi-Fi and radio signals, Inturai delivers next-generation spatial intelligence without the need for invasive or specialist hardware. This breakthrough enables safer, smarter spaces across a range of high-impact use cases. To learn more, visit This document contains certain forward-looking statements that are based on assumptions as of the date of this news release. Forward-looking statements are frequently characterised by words such as "anticipates", "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed", "positioned" and other similar words, or statements that certain events or conditions "may" or "will" occur. All such forward-looking statements involve substantial known and unknown risks and uncertainties, certain of which are beyond the Company's control. The reader is cautioned that the assumptions used in the preparation of the forward-looking statements may prove to be incorrect and the actual results, performance or achievements could differ materially from those expressed in, or implied by, these forward-looking statements. Accordingly, no assurances can be given that any of the events anticipated by the forward-looking statements will transpire or occur, or if any of them do, what benefits, including the amount of proceeds, the Company will derive therefrom. Readers are cautioned that the foregoing list of factors is not exhaustive. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law. View original content to download multimedia: SOURCE P2P Group Limited View original content to download multimedia: Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Cision Canada
19-06-2025
- Business
- Cision Canada
P2P Group Formalises Global Channel Partner Program as Onboarding Begins for First Four Partners
Highlights: Four selected partners are now progressing through onboarding for the Inturai Channel Partner Program, showing strong demand and uptake Partners targeting worldwide deployments initially across aged care, home security and energy management sectors 3-year sale targets are currently being finalised with the selected channel partners Click to Visit The Inturai YouTube Channel VANCOUVER, BC, June 19, 2025 /CNW/ - P2P Group Ltd. (CSE: PPB) (FSE: 3QG) (US: PPBGF) (the "Company") is pleased to announce that the Company has formalised its Channel Partner Program and has four initial partners who are now undergoing onboarding. These parties have been selected based on market reach, solution alignment and near-term commercialisation potential. The onboarding process is designed to prepare partners for deployment of Inturai's real-time spatial intelligence platform across sectors including aged care, home security and energy management sectors—where multiple regional rebate programs support adoption along with broader industrial and smart infrastructure use cases. Each of the onboarding partners is currently reviewing their three-year sales ambitions in collaboration with the Company. Once formalised and submitted, P2P Group will update the market with aggregate targets and commercial expectations. "This is a high-conviction program aimed at creating scaled, localised market entry through capable partners," said Ed Clarke, CEO of P2P Group. "The depth of interest across sectors is clear and impressive and we expect partner-led growth to be a major component of our commercial engine going forward." The Inturai Channel Partner Program enables selected integrators, system providers and sector specialists to deploy Inturai technology across high-impact environments—delivering continuous sensing, AI-driven intelligence and cost-efficient infrastructure with minimal hardware requirements. About P2P Group P2P Group is advancing intelligent environments through its proprietary Inturai AI signal sensing technology, transforming sectors including healthcare, defence, policing, emergency services, drones, smart homes, and industrial systems. By leveraging standard Wi-Fi and radio signals, Inturai delivers next-generation spatial intelligence without the need for invasive or specialist hardware. This breakthrough enables safer, smarter spaces across a range of high-impact use cases. To learn more, visit This document contains certain forward-looking statements that are based on assumptions as of the date of this news release. Forward-looking statements are frequently characterised by words such as "anticipates", "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed", "positioned" and other similar words, or statements that certain events or conditions "may" or "will" occur. All such forward-looking statements involve substantial known and unknown risks and uncertainties, certain of which are beyond the Company's control. The reader is cautioned that the assumptions used in the preparation of the forward-looking statements may prove to be incorrect and the actual results, performance or achievements could differ materially from those expressed in, or implied by, these forward-looking statements. Accordingly, no assurances can be given that any of the events anticipated by the forward-looking statements will transpire or occur, or if any of them do, what benefits, including the amount of proceeds, the Company will derive therefrom. Readers are cautioned that the foregoing list of factors is not exhaustive. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.
Cision Canada
11-06-2025
- Business
- Cision Canada
P2P Group Increases Biometric Detection Range by 166%--Transforming Security, Defence and Aged Care
Highlights: Opens new markets in border control, defence, and passive health monitoring Extends wireless heart rate and breathing detection range from 3m to 8m using standard Wi-Fi Enables detection of hidden individuals and weapons in vehicles and sealed environments from human or drone-operated devices. Click to join the public Inturai Telegram Channel VANCOUVER, BC, June 11, 2025 /CNW/ - P2P Group Ltd. (CSE: PPB) (FSE: 3QG) (US: PPBGF) is pleased to announce a major improvement in its wireless sensing platform, achieving heart rate and breathing detection at distances of up to 8 metres—more than doubling its prior range. This enhancement strengthens both the SafeWave and StealthWave systems and significantly increases addressable market applications: Border Security and Customs – Identifying concealed individuals in transport vehicles and closed compartments National Defence and Tactical Teams – Gathering biometric intelligence without line of sight Aged Care and Remote Health – Enabling unobtrusive, low-cost, and full room monitoring with no cameras, wearables, or privacy trade-offs "Expanding the range to 8 metres without adding complexity is a very meaningful leap," said Ed Clarke, CEO of P2P Group. "This capability pushes us into new operational zones where traditional solutions simply can't go." The Company is advancing IP protection, commercial rollout plans, and customer notifications. Updates will follow as deployment progresses. About P2P Group P2P Group is advancing intelligent environments through its proprietary Inturai AI signal sensing technology, transforming sectors including healthcare, defence, policing, emergency services, drones, smart homes, and industrial systems. By leveraging standard Wi-Fi and radio signals, Inturai delivers next-generation spatial intelligence without the need for invasive or specialist hardware. This breakthrough enables safer, smarter spaces across a range of high-impact use cases. To learn more, visit This document contains certain forward-looking statements that are based on assumptions as of the date of this news release. Forward-looking statements are frequently characterised by words such as "anticipates", "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed", "positioned" and other similar words, or statements that certain events or conditions "may" or "will" occur. All such forward-looking statements involve substantial known and unknown risks and uncertainties, certain of which are beyond the Company's control. The reader is cautioned that the assumptions used in the preparation of the forward-looking statements may prove to be incorrect and the actual results, performance or achievements could differ materially from those expressed in, or implied by, these forward-looking statements. Accordingly, no assurances can be given that any of the events anticipated by the forward-looking statements will transpire or occur, or if any of them do, what benefits, including the amount of proceeds, the Company will derive therefrom. Readers are cautioned that the foregoing list of factors is not exhaustive. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.
